Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
colorectal cancer
market7 mentionslast seen Nov 4, 2026
An indication being studied in HARMONi-GI3 trial.
Relationships 5
- ivonescimabapplies tocolorectal cancer100% confidence1 source
- stenoparibapplies tocolorectal cancer99% confidence2 sources
- pelareorepapplies tocolorectal cancer99% confidence2 sources
- ivonescimabapplies tocolorectal cancer99% confidence1 source
- [212Pb]PSV359applies tocolorectal cancer90% confidence1 source
Relationship
pelareorepapplies tocolorectal cancer
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGARNov 4, 2026ONCOLYTICS BIOTECH INC 8-K: Item 8.01: Other Events
pelareorep has received Fast Track designation from the U.S. Food and Drug Administration for colorectal, anal, and pancreatic cancer
- filingSEC EDGAROct 13, 2026ONCOLYTICS BIOTECH INC 8-K: Item 8.01: Other Events
pelareorep has received Fast Track designation from the U.S. Food and Drug Administration for colorectal, anal, and pancreatic cancer